In the context of the association between high Cav3.2 levels and poor prognosis in ER+ breast cancers, Cav3.2-mediated constitutive Ca2+-influx contributes to enhanced proliferation in the LNCaP prostate cancer cell line [62]. The gene discussed is CACNA1H; the disease is breast carcinoma.